NCT04496245View on ClinicalTrials.gov

Reducing Acute Severe Respiratory Events in Health Care Workers During the Covid-19 Pandemic With OM85

PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 24, 2020

Primary Completion Date

June 30, 2021

Study Completion Date

September 30, 2021

Conditions

Respiratory Viral InfectionCovid19

Interventions

DRUG

Broncho-Vaxom®

Broncho-Vaxom adult capsules® (OM85)

Trial Locations (3)

4032

The Prince Charles Hospital, Brisbane

4101

Queensland Children's Hospital, South Brisbane

4102

The Princess Alexandra Hospital, Brisbane

All Listed Sponsors

collaborator

Griffith University

OTHER

collaborator

The Prince Charles Hospital

OTHER_GOV

collaborator

Princess Alexandra Hospital, Brisbane, Australia

OTHER

collaborator

Telethon Kids Institute

OTHER

collaborator

Queensland Children's Hospital

OTHER_GOV

lead

The University of Queensland

OTHER

NCT04496245 - Reducing Acute Severe Respiratory Events in Health Care Workers During the Covid-19 Pandemic With OM85 | Biotech Hunter | Biotech Hunter